Cargando…
Heterogeneity of mammary lesions represent molecular differences
BACKGROUND: Human breast cancer is a heterogeneous disease, histopathologically, molecularly and phenotypically. The molecular basis of this heterogeneity is not well understood. We have used a mouse model of DCIS that consists of unique lines of mammary intraepithelial neoplasia (MIN) outgrowths, t...
Autores principales: | Namba, Ruria, Maglione, Jeannie E, Davis, Ryan R, Baron, Colin A, Liu, Stephenie, Carmack, Condie E, Young, Lawrence JT, Borowsky, Alexander D, Cardiff, Robert D, Gregg, Jeffrey P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762020/ https://www.ncbi.nlm.nih.gov/pubmed/17147824 http://dx.doi.org/10.1186/1471-2407-6-275 |
Ejemplares similares
-
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
por: Namba, Ruria, et al.
Publicado: (2005) -
The molecular biology of mammary intraepithelial neoplasia outgrowths
por: Namba, L, et al.
Publicado: (2003) -
Mammary carcinoma behavior is programmed in the precancer stem cell
por: Damonte, Patrizia, et al.
Publicado: (2008) -
Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin
por: Jessen, Katayoun Alavi, et al.
Publicado: (2004) -
Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice
por: Davie, Sarah A., et al.
Publicado: (2007)